COVID-19 in patients with CLL: Improved survival outcomes and update on management strategies Research Letter


Authors: Roeker, L. E.; Eyre, T. A.; Thompson, M. C.; Lamanna, N.; Coltoff, A. R.; Davids, M. S.; Baker, P. O.; Leslie, L.; Rogers, K. A.; Allan, J. N.; Cordoba, R.; Lopez-Garcia, A.; Antic, D.; Pagel, J. M.; Martinez-Calle, N.; García-Marco, J. A.; Hernández-Rivas, J. Á; Miras, F.; Coombs, C. C.; Österborg, A.; Hansson, L.; Seddon, A. N.; López Jiménez, J.; Wilson, M. R.; El-Sharkawi, D.; Wojenski, D.; Ma, S.; Munir, T.; Valenciano, S.; Seymour, E.; Barr, P. M.; Pu, J.; Patten, P. E. M.; Perini, G. F.; Huntington, S. F.; Parry, H.; Sundaram, S.; Skarbnik, A.; Kamdar, M.; Jacobs, R.; Walter, H.; Walewska, R.; Broom, A.; Lebowitz, S.; Isaac, K. M.; Portell, C. A.; Ahn, I. E.; Ujjani, C. S.; Shadman, M.; Skånland, S.; Chong, E. A.; Mato, A. R.
Title: COVID-19 in patients with CLL: Improved survival outcomes and update on management strategies
Journal Title: Blood
Volume: 138
Issue: 18
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2021-11-04
Start Page: 1768
End Page: 1773
Language: English
DOI: 10.1182/blood.2021011841
PROVIDER: scopus
PMCID: PMC8313815
PUBMED: 34297826
DOI/URL:
Notes: Article -- Export Date: 1 December 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anthony R Mato
    235 Mato
  2. Lindsey Elizabeth Roeker
    132 Roeker